Creon
In the US, Creon (pancrelipase systemic) is a member of the drug class digestive enzymes and is used to treat Chronic Pancreatitis, Cystic Fibrosis and Pancreatic Exocrine Dysfunction.
US matches:
UK matches:
- CREON 40 000 CAPSULES (Leaflet)
- CREON 10 000 CAPSULES (Leaflet)
- CREON 10000 CAPSULES (Leaflet)
- CREON 25 000 CAPSULES (Leaflet)
- CREON 25000 CAPSULES (Leaflet)
- CREON 40000 CAPSULES (Leaflet)
- CREON MICRO PANCREATIN 60.12 MG GASTRO-RESISTANT GRANULES (Leaflet)
- CREON MICRO PANCREATIN 60.12MG GASTRO-RESISTANT GRANULES (Leaflet)
Ingredient matches for Creon
Pancreatin is reported as an ingredient of Creon in the following countries:
- Argentina
- Australia
- Belgium
- Brazil
- Canada
- Chile
- China
- Finland
- Greece
- Iceland
- Ireland
- Israel
- Malaysia
- Malta
- Mexico
- Netherlands
- New Zealand
- Norway
- Peru
- Philippines
- Singapore
- South Africa
- Sweden
- Switzerland
- Thailand
- United Kingdom
Pancrelipase is reported as an ingredient of Creon in the following countries:
- Italy
- United States
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
